{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T16:22:56Z","timestamp":1782145376096,"version":"3.54.5"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Brain Tumor Pathol"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s10014-021-00410-5","type":"journal-article","created":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T14:02:51Z","timestamp":1626444171000},"page":"183-188","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Molecular, functional, and histopathological classification of the pituitary neuroendocrine neoplasms"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7862-5559","authenticated-orcid":false,"given":"Chie","family":"Inomoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeyuki","family":"Tahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Oyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Midori","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Matsuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Teramoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert Y.","family":"Osamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,16]]},"reference":[{"key":"410_CR1","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/nrc926","volume":"2","author":"SL Asa","year":"2002","unstructured":"Asa SL, Ezzat S (2002) The pathogenesis of pituitary tumours. Nat Rev Cancer 2:836\u2013849","journal-title":"Nat Rev Cancer"},{"key":"410_CR2","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/noy131","volume":"20","author":"QT Ostrom","year":"2018","unstructured":"Ostrom QT, Gittleman H, Truitt G, Boscia A, Kruchko C, Barnholtz-Sloan JS (2018) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011\u20132015. Neuro Oncol 20:iv1\u2013iv86","journal-title":"Neuro Oncol"},{"key":"410_CR3","unstructured":"Osamura RY, Grossman A, Korbonits M, Kovacs K, Lopes MBS, Matsuno A et al (2017) Pituitary adenoma. In: Lloyd RV, Osamura RY, Kl\u00f6ppel G, Rosai J (eds) WHO classification of tumours of endocrine organs. Chapter 1: tumors of the pituitary gland. WHO, Lyon, p 14\u201318"},{"key":"410_CR4","doi-asserted-by":"publisher","first-page":"C5","DOI":"10.1530\/ERC-17-0004","volume":"24","author":"SL Asa","year":"2017","unstructured":"Asa SL, Casar-Borota O, Chanson P, Delgrange E, Earls P, Ezzat S et al (2017) From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal. Endocr Relat Cancer 24:C5\u2013C8","journal-title":"Endocr Relat Cancer"},{"key":"410_CR5","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1038\/s41379-018-0110-y","volume":"31","author":"G Rindi","year":"2018","unstructured":"Rindi G, Klimstra DS, Abedi-Ardekani B, Asa SL, Bosman FT, Brambilla E, Busam KJ et al (2018) A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal. Mod Pathol 31:1770\u20131786","journal-title":"Mod Pathol"},{"key":"410_CR6","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s11102-019-00988-2","volume":"22","author":"KKY Ho","year":"2019","unstructured":"Ho KKY, Fleseriu M, Wass J, van der Lely A, Barkan A, Giustina A et al (2019) A tale of pituitary adenomas: to NET or not to NET: pituitary Society position statement. Pituitary 22:569\u2013573","journal-title":"Pituitary"},{"key":"410_CR7","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1210\/jc.2018-00688","volume":"104","author":"J Drummond","year":"2019","unstructured":"Drummond J, Roncaroli F, Grossman AB, Korbonits M (2019) Clinical and pathological aspects of silent pituitary adenomas. J Clin Endocrinol Metab 104:2473\u20132489","journal-title":"J Clin Endocrinol Metab"},{"key":"410_CR8","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s00401-017-1768-9","volume":"134","author":"E Sj\u00f6stedt","year":"2017","unstructured":"Sj\u00f6stedt E, Bollerslev J, Mulder J, Lindskog C, Pont\u00e9n F, Casar-Borota O (2017) A specific antibody to detect transcription factor T-Pit: a reliable marker of corticotroph cell differentiation and a tool to improve the classification of pituitary neuroendocrine tumours. Acta Neuropathol 134:675\u2013677","journal-title":"Acta Neuropathol"},{"key":"410_CR9","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/modpathol.2015.151","volume":"29","author":"O Mete","year":"2016","unstructured":"Mete O, Gomez-Hernandez K, Kucharczyk W, Ridout R, Zadeh G, Gentili F et al (2016) Silent subtype 3 pituitary adenomas are not always silent and represent poorly differentiated monomorphous plurihormonal Pit-1 lineage adenomas. Mod Pathol 29:131\u2013142","journal-title":"Mod Pathol"},{"key":"410_CR10","first-page":"610","volume":"33","author":"E Knosp","year":"1993","unstructured":"Knosp E, Steiner E, Kitz K, Matula C (1993) Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery 33:610\u2013617","journal-title":"Neurosurgery"},{"key":"410_CR11","doi-asserted-by":"publisher","first-page":"803","DOI":"10.3171\/2014.12.JNS141083","volume":"122","author":"ASG Micko","year":"2015","unstructured":"Micko ASG, W\u00f6hrer A, Wolfsberger S, Knosp E (2015) Invasion of the cavernous sinus space in pituitary adenomas: endoscopic verification and its correlation with an MRI-based classification. J Neurosurg 122:803\u2013811","journal-title":"J Neurosurg"},{"key":"410_CR12","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s00428-019-02655-0","volume":"475","author":"C Villa","year":"2019","unstructured":"Villa C, Vasiljevic A, Jaffrain-Rea ML, Ansorge O, Asioli S, Barresi V et al (2019) A standardised diagnostic approach to pituitary neuroendocrine tumours (PitNETs): a European Pituitary Pathology Group (EPPG) proposal. Virch Arch 475:687\u2013692","journal-title":"Virch Arch"},{"key":"410_CR13","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3390\/cancers12020514","volume":"12","author":"J Trouillas","year":"2020","unstructured":"Trouillas J, Jaffrain-Rea M, Vasiljevic A, Raverot G, Roncaroli F, Villa C (2020) How to classify pituitary neuroendocrine tumors (PitNET)s in 2020. Cancers 12:514","journal-title":"Cancers"},{"key":"410_CR14","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3171\/jns.2002.96.2.0195","volume":"96","author":"BP Meij","year":"2002","unstructured":"Meij BP, Lopes MBS, Ellegala DB, Alden TD, Laws ER (2002) The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery. J Neurosurg 96:195\u2013208","journal-title":"J Neurosurg"},{"key":"410_CR15","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-17-0796","volume":"178","author":"G Raverot","year":"2017","unstructured":"Raverot G, Burman P, McCormack A, Heaney A, Petersenn S, Popovic V et al (2017) European Society of Endocrinology clinical practice guidelines for the management of aggressive pituitary tumours and carcinomas. Eur J Endocrinol 178:G1\u2013G24","journal-title":"Eur J Endocrinol"},{"key":"410_CR16","doi-asserted-by":"publisher","first-page":"3368","DOI":"10.1210\/jc.2017-00773","volume":"102","author":"G Raverot","year":"2017","unstructured":"Raverot G, Dantony E, Beauvy J, Vasiljevic A, Mikolasek S, Borson-Chazot F et al (2017) Risk of recurrence in pituitary neuroendocrine tumors: a prospective study using a five-tiered classification. J Clin Endocrinol Metab 102:3368\u20133374","journal-title":"J Clin Endocrinol Metab"},{"key":"410_CR17","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-17-0796","volume":"178","author":"G Raverot","year":"2018","unstructured":"Raverot G, Burman P, McCormack A, Heaney A, Petersenn S, Popovic V, Trouillas J, Dekkers OM (2018) European Society of Endocrinology European Society of Endocrinology clinical practice guidelines for the management of aggressive pituitary tumours and carcinomas. Eur J Endocrinol 178:G1\u2013G24","journal-title":"Eur J Endocrinol"},{"key":"410_CR18","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3389\/fendo.2019.00334","volume":"10","author":"C Dai","year":"2019","unstructured":"Dai C, Liu X, Ma W, Wang R (2019) The treatment of refractory pituitary adenomas. Front Endocrinol (Lausanne) 10:334","journal-title":"Front Endocrinol (Lausanne)"},{"key":"410_CR19","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3390\/jcm9010030","volume":"9","author":"C Tatsi","year":"2019","unstructured":"Tatsi C, Stratakis CA (2019) The genetics of pituitary adenomas. J Clin Med 9:30","journal-title":"J Clin Med"},{"key":"410_CR20","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1210\/endrev\/bnaa006","volume":"41","author":"V Srirangam Nadhamuni","year":"2020","unstructured":"Srirangam Nadhamuni V, Korbonits M (2020) Novel insights into pituitary tumorigenesis: genetic and epigenetic mechanisms. Endocr Rev 41:821\u2013846","journal-title":"Endocr Rev"},{"key":"410_CR21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12022-021-09663-4","volume":"32","author":"SL Asa","year":"2021","unstructured":"Asa SL, Mete O, Ezzat S (2021) Genomics and epigenomics of pituitary tumors: what do pathologists need to know? Endocr Pathol 32:3\u201316","journal-title":"Endocr Pathol"},{"key":"410_CR22","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.3390\/jcm10071377","volume":"10","author":"A Boguslawska","year":"2021","unstructured":"Boguslawska A, Korbonits M (2021) Genetics of acromegaly and gigantism. J Clin Med 10:1377","journal-title":"J Clin Med"},{"key":"410_CR23","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1210\/clinem\/dgaa749","volume":"106","author":"O Casar-Borota","year":"2021","unstructured":"Casar-Borota O, Boldt HB, Engstrom BE, Andersen MS, Baussart B, Bengtsson D et al (2021) Corticotroph aggressive pituitary tumors and carcinomas frequently harbor ATRX mutations. J Clin Endocrinol Metab 106:1183\u20131194","journal-title":"J Clin Endocrinol Metab"},{"key":"410_CR24","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s12020-021-02633-0","volume":"71","author":"J Denes","year":"2021","unstructured":"Denes J, Korbonits M (2021) The clinical aspects of pituitary tumour genetics. Endocrine 71:663\u2013674","journal-title":"Endocrine"},{"key":"410_CR25","doi-asserted-by":"publisher","unstructured":"Spada A, Mantovani G, Treppiedi D, Mangili F, Catalano R, Carosi G et al (2021) Pituitary tumors: genetic and molecular factors underlying pathogenesis and clinical behavior. Neuroendocrinol. https:\/\/doi.org\/10.1159\/000514862","DOI":"10.1159\/000514862"},{"key":"410_CR26","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ccell.2019.11.002","volume":"37","author":"M Neou","year":"2020","unstructured":"Neou M, Villa C, Armignacco R, Jouinot A, Raffin-Sanson ML, Septier A et al (2020) Pangenomic classification of pituitary neuroendocrine tumors. Cancer Cell 37:123\u2013134","journal-title":"Cancer Cell"}],"container-title":["Brain Tumor Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10014-021-00410-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10014-021-00410-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10014-021-00410-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T03:36:11Z","timestamp":1627443371000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10014-021-00410-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["410"],"URL":"https:\/\/doi.org\/10.1007\/s10014-021-00410-5","relation":{},"ISSN":["1433-7398","1861-387X"],"issn-type":[{"value":"1433-7398","type":"print"},{"value":"1861-387X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"14 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}